Minimal change oesophagitis: A disease with characteristic differences to erosive oesophagitis

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 21, Issue 2, 2005, Pages 19-26

  Nakamura, T ^a   Shirakawa, K ^a   Masuyama, H ^b   Sugaya, H ^a   Hiraishi, H ^a   Terano, A ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Musuyama Gastrointesitinal Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAMOTIDINE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BILE REFLUX; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG EFFECT; ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL CHANGE ESOPHAGITIS; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REFLUX ESOPHAGITIS; TREATMENT OUTCOME;

EID: 20444366945     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02469.x     Document Type: Article

References (21)

1. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100: 190-200.
2. Fock KM, Talley N, Hunt R, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol 2004; 19: 357-67.
3. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
4. Furukawa N, Iwakiri R, Koyama T, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol 1999; 34: 441-4.
5. Fujimoto K, Iwakiri R, Okamoto K, et al. Characteristics of gastroesophageal reflux disease in Japan: increased prevalence in elderly women. J Gastroenterol 2003; 38 (Suppl. 15): 3-6.
6. Inamori M, Togawa J, Nagase H, et al. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification. J Gastroenterol Hepatol 2003; 18: 172-6.
7. Hoshihara Y. Endoscopic findings of GERD (in Japanese). Nippon Rinsho 2004; 62: 1459-64.
8. Storr M, Meining A. Pharmacologic management and treatment of gastroesophageal reflux disease. Dis Esophagus 2004; 17: 197-204.
9. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33: 1023-9.
10. Avidan B, Sonnenberg A, Schnell TG, et al. Risk factors for erosive reflux esophagitis: a case-control study. Am J Gastroenterol 2001; 96: 41-6.
11. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97.
12. Vianna A, Hayes PC, Moscoso G, et al. Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology 1987; 93: 876-89.
13. Kiesslich R, Kanzler S, Vieth M, et al. Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig Dis 2004; 22: 221-7.
14. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92.
15. Gatopoulou A, Mimidis K, Giatromanolaki A, et al. Impact of hiatal hernia on histological pattern of non-erosive reflux disease. BMC Gastroenterol 2005; 5: 2 [Epub ahead of print].
16. Gordon C, Kang JY, Neild PJ, et al. The role of the hiatus hernia in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 20: 719-32.
17. Tack J, Koek G, Demedts I, et al. Gastroesopliageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both? Am J Gastroenterol 2004; 99: 981-8.
18. Fallone CA, Barkun AN, Mayrand S, et al There is no difference in the disease severity of gastro-oesophageal reflux disease between patients infected and not infected with Helicobacter pylori. Aliment Pharmacol Ther 2004; 20: 761-8.
19. Haruma K, Kamada T, Kawaguchi H, et al. Effect of age and Hdicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol 2000; 15: 277-83.
20. Soga T, Matsuura M, Kodama Y, et al. Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis? J Gastroenterol 1999; 34: 435-40.
21. van Pinxteren B, Numans ME, Lau J, et al. Short-term treatment of gastroesophageal reflux disease. J Gen Intern Med 2003; 18: 755-63.